The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology-Reference-Cited by-同舟云学术

The Use of Patient-reported Outcomes in Demonstrating Safety and Efficacy in Oncology

Published:2016-04 Issue:4 Volume:38 Page:756-758
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Coon Cheryl D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Endpoints for assessing drug activity in clinical trials;Pazdur;Oncologist,2008

2. Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms;Kluetz;Clin Cancer Res,2016

3. JAKAFI™ (ruxolitinib). Label and Approval History,2011

4. Institute for Quality and Efficiency in Health Care. IQWiG Reports No. 162. Addendum to Commission A12-15 (crizotinib). Cologne, Germany: Institute for Quality and Efficiency in Health Care; 2013.

5. Eribulin for the treatment of locally advanced or metastatic breast cancer. Technology appraisal guidance,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robotic versus laparoscopic hepatectomy for liver malignancies (ROC'N'ROLL): a single-centre, randomised, controlled, single-blinded clinical trial;The Lancet Regional Health - Europe;2024-08

2. The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997–2022);The Lancet Digital Health;2023-03

3. Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile Application;JCO Clinical Cancer Informatics;2019-12

4. The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis;Health and Quality of Life Outcomes;2019-10-16

5. Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients;JMIR Cancer;2017-08-07